Alyeska Investment Group
JNJ icon

Alyeska Investment Group’s Johnson & Johnson JNJ Stock Holding History

Alyeska Investment Group’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$298M Buy
1,173,482
+338,790
+41% +$79M 0.77% 16
2026
Q1 		$204M Sell
834,692
-103,697
-11% -$24.2M 0.58% 35
2025
Q4 		$194M Buy
938,389
+193,070
+26% +$38.2M 0.55% 32
2025
Q3 		$138M Buy
745,319
+202,778
+37% +$34.7M 0.42% 47
2025
Q2 		$82.9M Buy
542,541
+408,814
+306% +$62.8M 0.29% 96
2025
Q1 		$22.2M Sell
133,727
-700,342
-84% -$110M 0.09% 233
2024
Q4 		$121M Buy
834,069
+102,255
+14% +$15.8M 0.45% 50
2024
Q3 		$119M Buy
731,814
+305,786
+72% +$48.7M 0.61% 37
2024
Q2 		$62.3M Sell
426,028
-188,972
-31% -$28.1M 0.36% 93
2024
Q1 		$97.3M Buy
615,000
+235,000
+62% +$37.4M 0.6% 43
2023
Q4 		$59.6M Buy
+380,000
New +$58.3M 0.39% 80
2020
Q2 		– Sell
-14,398
Closed -$1.89M – 533
2020
Q1 		$1.89M Buy
14,398
+10,236
+246% +$1.45M 0.04% 263
2019
Q4 		$607K Sell
4,162
-252,664
-98% -$34.3M 0.01% 347
2019
Q3 		$33.2M Buy
+256,826
New +$33.8M 0.48% 72
2019
Q2 		– Sell
-2,990
Closed -$418K – 482
2019
Q1 		$418K Buy
+2,990
New +$401K 0.01% 351
2018
Q1 		– Sell
-300,324
Closed -$42M – 476
2017
Q4 		$42M Buy
300,324
+6,338
+2% +$883K 0.33% 98
2017
Q3 		$38.2M Buy
+293,986
New +$39M 0.29% 116
2017
Q1 		– Sell
-464,345
Closed -$53.5M – 523
2016
Q4 		$53.5M Buy
+464,345
New +$53.6M 0.44% 73
2016
Q3 		– Sell
-693,731
Closed -$84.2M – 496
2016
Q2 		$84.2M Buy
693,731
+43,663
+7% +$4.96M 0.79% 20
2016
Q1 		$70.3M Buy
650,068
+108,532
+20% +$11.2M 0.65% 39
2015
Q4 		$55.6M Buy
541,536
+495,930
+1,087% +$49.9M 0.59% 50
2015
Q3 		$4.26M Buy
+45,606
New +$4.41M 0.05% 262

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Alyeska Investment Group's JNJ Position: Q2 2026 in Review

Alyeska Investment Group increased its Johnson & Johnson (JNJ) stake by 41% in Q2 2026, buying an estimated $79M and bringing the position to 1,173,482 shares worth $298M. The position accounts for 0.77% of the portfolio, ranked #16.

Alyeska Investment Group first reported a position in JNJ in Q3 2015 and has held it in 22 quarters since. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Alyeska Investment Group held 1,173,482 shares of Johnson & Johnson worth $298M as of Q2 2026.
  • Alyeska Investment Group bought 338,790 Johnson & Johnson shares in Q2 2026, an estimated $79M.
  • Johnson & Johnson made up 0.77% of Alyeska Investment Group's portfolio in Q2 2026, its #16 holding.
  • Alyeska Investment Group first reported a position in Johnson & Johnson in Q3 2015 and has held it in 22 quarters since.
  • 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.